Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
March 28, 2024
Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of ...
Blog Post
March 12, 2024
When it comes to disaster- and climate-related displacement, the Asia-Pacific is ground zero. More than three-quarters of internal disaster displacements occur in the region, with over 225 million displacements between 2010 and 2021. This is set to increase. The number of internally displaced people...
Blog Post
February 09, 2024
Indonesia’s upcoming presidential election carries high stakes, demanding strong leadership to address long-standing challenges in child malnutrition and stunting at this pivotal moment. The issue of child stunting has become a flash point among the numerous campaign pledges for health and nutrition...
Blog Post
October 23, 2023
In times of mounting debt, the quest for universal health coverage (UHC) faces critical challenges. Rising debt has far-reaching effects, including reduced access to financing, political instability, and decreased spending on international aid. The burden of debt, coupled with high inflation, is thr...
Blog Post
May 22, 2023
The tide is turning: the economic recovery in the Asia-Pacific region is picking up steam. Last week’s forecasts from the IMF suggest that economic growth in the region’s developing and emerging countries will rise from 4.4 percent in 2022 to 5.3 and 5.1 percent in the current and following year. Th...
Blog Post
May 11, 2023
IF-CAP is a donor-backed guarantee facility, where public, private, and philanthropic financing partners take risk off the ADB’s balance sheet by guaranteeing to backstop repayments for ADB mitigation and adaptation climate projects. By guaranteeing repayments on specific climate investments, IF-CA...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...